Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis
Despite lack of primary FQ ABP, low rates of bacteremia were observed during the pre-engraftment period, with low MDRO prevalence and mortality. Our findings may allow to revisit the need for primary universal FQ ABP in high-risk neutropenic hematology patients.
Authors
- Stavroula Masouridi‐Levrat (ORCID: https://orcid.org/0000-0001-7502-5454)
- Dionysios Neofytos (ORCID: https://orcid.org/0000-0001-6970-2869)
- Maria Mappoura (ORCID: https://orcid.org/0000-0001-9499-7865)
- Adrien Fischer (ORCID: https://orcid.org/0000-0002-5437-4804)
- Johan Courjon (ORCID: https://orcid.org/0000-0002-0445-5104)
- Sarah Morin (ORCID: https://orcid.org/0009-0003-5740-2035)
- Anne‐Claire Mamez (ORCID: https://orcid.org/0000-0002-8666-7089)
- Yves Chalandon (ORCID: https://orcid.org/0000-0001-9341-8104)
- Federica Giannotti
- Aude Nguyen (ORCID: https://orcid.org/0000-0002-9640-5146)
- Jordan Fender
Institutions
- University of Geneva (CH)
- Centre Hospitalier Universitaire de Nice (FR)
- University Hospital of Geneva (CH)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1111/tid.14375
- Citations
- 1
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Hôpitaux Universitaires de Genève